Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 01, 2024

SELL
$114.26 - $136.0 $29.8 Million - $35.4 Million
-260,413 Reduced 55.34%
210,186 $25.9 Million
Q3 2023

Oct 31, 2023

BUY
$122.0 - $145.31 $1.78 Million - $2.12 Million
14,581 Added 3.2%
470,599 $60.9 Million
Q2 2023

Aug 03, 2023

BUY
$122.5 - $147.16 $582,242 - $699,451
4,753 Added 1.05%
456,018 $56.5 Million
Q1 2023

Apr 26, 2023

SELL
$133.98 - $160.47 $1.45 Million - $1.74 Million
-10,848 Reduced 2.35%
451,265 $66 Million
Q4 2022

Feb 09, 2023

BUY
$129.72 - $159.85 $2.12 Million - $2.61 Million
16,352 Added 3.67%
462,113 $73.6 Million
Q3 2022

Nov 01, 2022

BUY
$126.59 - $161.18 $17.3 Million - $22 Million
136,361 Added 44.07%
445,761 $59.4 Million
Q2 2022

Aug 02, 2022

BUY
$141.59 - $168.66 $24.9 Million - $29.7 Million
175,916 Added 131.79%
309,400 $48.3 Million
Q1 2022

May 11, 2022

BUY
$129.64 - $160.7 $3.4 Million - $4.22 Million
26,253 Added 24.48%
133,484 $20.8 Million
Q4 2021

Feb 08, 2022

BUY
$119.87 - $145.67 $244,654 - $297,312
2,041 Added 1.94%
107,231 $13.7 Million
Q3 2021

Nov 09, 2021

SELL
$128.64 - $184.79 $31 Million - $44.5 Million
-240,716 Reduced 69.59%
105,190 $13.7 Million
Q2 2021

Aug 12, 2021

BUY
$160.2 - $186.42 $17.3 Million - $20.1 Million
107,834 Added 45.29%
345,906 $61.4 Million
Q1 2021

May 11, 2021

BUY
$150.19 - $173.5 $5.57 Million - $6.44 Million
37,105 Added 18.46%
238,072 $39.1 Million
Q4 2020

Feb 05, 2021

BUY
$140.71 - $165.05 $28.3 Million - $33.2 Million
200,967 New
200,967 $33.2 Million
Q1 2020

May 06, 2020

SELL
$87.74 - $152.74 $366,402 - $637,842
-4,176 Closed
0 $0
Q4 2019

Feb 07, 2020

BUY
$117.65 - $153.73 $491,306 - $641,976
4,176 New
4,176 $623,000
Q1 2019

May 10, 2019

SELL
$121.81 - $142.95 $517,083 - $606,822
-4,245 Closed
0 $0
Q4 2018

Feb 06, 2019

BUY
$115.94 - $166.74 $492,165 - $707,811
4,245 New
4,245 $526,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.7B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Jennison Associates LLC Portfolio

Follow Jennison Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.